Insights

Aesthetic Market Expansion QuantifiCare's new Quartier Latin spin-off dedicated to aesthetic imaging signals a focused growth channel in cosmetic clinics and related CRO opportunities, enabling cross-sell of 2D/3D imaging devices and integrated workflow solutions for trials and clinics.

Cloud Platform Upsell The LifeViz Neo Cloud Software launch offers a cloud based workflow for clinics no longer under Serenity, creating a pathway to recurring software revenue alongside hardware sales and clinical trial services.

Credible Differentiation Repeated Best Aesthetic Device awards, including DermaViz UV, position QuantifiCare as a premium, validated imaging vendor and strengthen value propositions for high end aesthetics clinics and sponsor-sponsored trials.

Global and Events Momentum Operations in the United States and France, plus high profile events like AMWC and awards, give access to global clinician networks and multinational pharma and cosmetics brands for multi market imaging deployments.

Competitive Positioning Active competitive stance, including legal action against Canfield Scientific, signals a defensible technology moat and can be leveraged in sales conversations around IP protected imaging capabilities and long term partnerships.

Quantificare Tech Stack

Quantificare uses 8 technology products and services including Google Fonts API, JSON-LD, jQuery UI, and more. Explore Quantificare's tech stack below.

  • Google Fonts API
    Font Scripts
  • JSON-LD
    Javascript Frameworks
  • jQuery UI
    Javascript Libraries
  • OWL Carousel
    Javascript Libraries
  • Microsoft Office
    Office Suites
  • Divi
    Page Builders
  • Express.js
    Web Frameworks
  • Buttonizer
    Widgets

Media & News

Quantificare's Email Address Formats

Quantificare uses at least 1 format(s):
Quantificare Email FormatsExamplePercentage
FLast@quantificare.comJDoe@quantificare.com
56%
First.Last@quantificare.comJohn.Doe@quantificare.com
41%
First.Middle@quantificare.comJohn.Michael@quantificare.com
1%
Last@quantificare.comDoe@quantificare.com
2%

Frequently Asked Questions

What is Quantificare's phone number?

Minus sign iconPlus sign icon
You can contact Quantificare's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Quantificare's official website and social media links?

Minus sign iconPlus sign icon
Quantificare's official website is quantificare.com and has social profiles on LinkedInCrunchbase.

What is Quantificare's SIC code NAICS code?

Minus sign iconPlus sign icon
Quantificare's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Quantificare have currently?

Minus sign iconPlus sign icon
As of July 2026, Quantificare has approximately 120 employees across 4 continents, including EuropeNorth AmericaSouth America. Key team members include Chief Executive Officer: D. D.Cfo: P. B.Chief Business Officer - Clinical Services: N. D.. Explore Quantificare's employee directory with LeadIQ.

What industry does Quantificare belong to?

Minus sign iconPlus sign icon
Quantificare operates in the Biotechnology Research industry.

What technology does Quantificare use?

Minus sign iconPlus sign icon
Quantificare's tech stack includes Google Fonts APIJSON-LDjQuery UIOWL CarouselMicrosoft OfficeDiviExpress.jsButtonizer.

What is Quantificare's email format?

Minus sign iconPlus sign icon
Quantificare's email format typically follows the pattern of FLast@quantificare.com. Find more Quantificare email formats with LeadIQ.

How much funding has Quantificare raised to date?

Minus sign iconPlus sign icon
As of July 2026, Quantificare has raised $5.5M in funding. The last funding round occurred on Sep 05, 2019 for $5.5M.
Quantificare logo

Quantificare

Biotechnology ResearchUnited States51-200 Employees

Quantificare is a United States-based biotechnology research firm that operates as an imaging-focused contract research organization. It provides imaging services for clinical trials from preclinical stages through Phase IV, spanning a broad range of therapeutic areas. Its client base includes pharmaceutical and biotech companies as well as the cosmetics industry, leveraging imaging data to inform trial design and assessment.

The company operates with a mid-sized team. In late 2025, Quantificare announced the creation of Quartier Latin, a spin-off dedicated to the aesthetic imaging market, with the launch effective January 1, 2026. This development expands the group's footprint into cosmetic imaging.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $5.5M

    Quantificare has raised a total of $5.5M of funding over 1 rounds. Their latest funding round was raised on Sep 05, 2019 in the amount of $5.5Mas a series_a.

  • $10M$25M

    Quantificare's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $5.5M

    Quantificare has raised a total of $5.5M of funding over 1 rounds. Their latest funding round was raised on Sep 05, 2019 in the amount of $5.5Mas a series_a.

  • $10M$25M

    Quantificare's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.